Edwards Lifesciences | Ativo Circulante





Ativo Circulante Alterar Data
Abbott USD 26B 1.16B 2025-12
Artivion USD 337.5M 18.68M 2025-09
AtriCure USD 322.52M 21.41M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cooper Companies USD 2.11B 31.4M 2025-09
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Globus Medical USD 1.92B 194.46M 2025-09
Hologic USD 3.84B 175.3M 2025-12
ICU Medical USD 1.19B 16.74M 2025-12
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.14B 754K 2025-09
Intuitive Surgical USD 12.4B 927.3M 2025-12
J&J USD 55.62B 1.01B 2025-12
Masimo USD 1.05B 221.5M 2025-09
Medtronic USD 24B 773M 2025-09
Merit Medical Systems USD 985.53M 62.46M 2025-09
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.99B 262.12M 2025-09
Zimmer Biomet Holdings USD 5.12B 715M 2025-12


Edwards Lifesciences Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.